Life Sciences/Biotech

Big Opportunity for Small Tech Companies

ANN ARBOR - The MPowered Career Fair is right around the corner. If your technology or life science company is looking for super-smart, full- or part-time student-power - you'll find it at the University of Michigan on Feb. 11. This event is designed specifically for small businesses to connect with U-M students for both full-time

By |2009-01-20T00:00:00-05:00January 20th, 2009|Archive, Life Sciences/Biotech|

BioArbor: Experienced Scientific Founders Share Their Stories

ANN ARBOR - You have invented a new technology, but how can you start a company to commercialize this technology? BioArbor has assembled an expert panel of three scientists who have successfully started companies and will speak to issues critical in starting companies, building teams, developing technology into products and funding ventures. Speakers: David Humes,

By |2009-01-13T00:00:00-05:00January 13th, 2009|Archive, Life Sciences/Biotech|

Perrigo Announces FDA Final Approval for Ibuprofen PM

ALLEGAN - Perrigo Company Monday announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for over-the-counter Ibuprofen and Diphenhydramine Citrate Tablets, 200/38 mg. Perrigo is expecting to begin product shipments to retailers during the first quarter of calendar year 2009. The product will be

By |2008-12-30T00:00:00-05:00December 30th, 2008|Archive, Life Sciences/Biotech|

Corrections Hires Tennessee Company To Provide Prisoner Health Care

LANSING - Bidding on providing physicians and hospital care for prisoners has yielded a new provider for the Department of Corrections, a company based in Tennessee, according to reports. Prison Health Services, based in Brentwood, Tennessee, will reportedly take over the prison healthcare system in April, replacing Correctional Medical Services for the $326 million contract.

By |2008-12-23T00:00:00-05:00December 23rd, 2008|Archive, Life Sciences/Biotech|

U-M To Buy Ann Arbor Pfizer R&D Labs For $108 Million

ANN ARBOR - The University of Michigan announced plans Thursday to purchase the former Pfizer R&D facilities for $108 million. U-M officials said the move will directly create at least 2,000 jobs during the next decade and accelerate expansion of the nation's second ranked research university's activities, so critical to the state's economic development. "This

By |2008-12-18T00:00:00-05:00December 18th, 2008|Archive, Life Sciences/Biotech|

Health IT Spending Increasing Nationwide

LANSING - As part of an effort to address health care issues on a statewide level, many states have turned to health information technology as a way to reform the system, according to a recent report from the National Conference of State Legislatures. NCSL documented a surge in health information technology initiatives, noting that of

By |2008-12-16T00:00:00-05:00December 16th, 2008|Archive, Life Sciences/Biotech|

Van Andel Institute Honors Developers Of Breast Cancer Drug

GRAND RAPIDS - Van Andel Institute honored Dennis J. Slamon, M.D., Ph.D., and biotechnology company Genentech, with the 2007 Daniel Nathans Memorial Award for their roles in the development of the breast cancer drug Herceptin. Slamon and Arthur D. Levinson, Ph.D., who accepted the award on behalf of Genentech, presented lectures to the public this

By |2008-12-15T00:00:00-05:00December 15th, 2008|Archive, Life Sciences/Biotech|

Van Andel Institute Researcher Named to NIH Study Section

GRAND RAPIDS - Senior Scientific Investigator Bart Williams, Ph.D., head of Van Andel Institute's Laboratory of Cell Signaling and Carcinogenesis, was named in September to a post on the National Institute of Heath Study section. Williams will serve as a member of the Skeletal Biology Development and Disease Study Section, Center for Scientific Review, for

By |2008-11-20T00:00:00-05:00November 20th, 2008|Archive, Life Sciences/Biotech|